Search Results - "FINCH, C. N"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Risk Factors for Development of Chronic Kidney Disease in Cats by Finch, N.C., Syme, H.M., Elliott, J.

    Published in Journal of veterinary internal medicine (01-03-2016)
    “…BACKGROUND: Identification of risk factors for development of chronic kidney disease (CKD) in cats may aid in its earlier detection. HYPOTHESIS/OBJECTIVES:…”
    Get full text
    Journal Article
  2. 2

    Thyroid and renal function in cats following low‐dose radioiodine (111Mbq) therapy by Finch, N. C., Stallwood, J., Tasker, S., Hibbert, A.

    Published in Journal of small animal practice (01-09-2019)
    “…Objectives To describe the effect of low‐dose (111MBq) radioiodine therapy on thyroid and renal function in hyperthyroid cats over a 12‐month follow‐up period…”
    Get full text
    Journal Article
  3. 3

    What outcomes should be measured in feline chronic kidney disease treatment trials? Establishing a core outcome set for research by Doit, H., Dean, R.S., Duz, M., Finch, N.C., Brennan, M.L.

    Published in Preventive veterinary medicine (01-07-2021)
    “…Chronic Kidney Disease (CKD) is an important cause of feline morbidity and mortality. There is currently no agreement on which outcomes are most important in…”
    Get full text
    Journal Article
  4. 4

    Fibroblast Growth Factor 23 (FGF-23) Concentrations in Cats with Early Nonazotemic Chronic Kidney Disease (CKD) and in Healthy Geriatric Cats by Finch, N.C., Geddes, R.F., Syme, H.M., Elliott, J.

    Published in Journal of veterinary internal medicine (01-03-2013)
    “…Background Fibroblast growth factor (FGF‐23) has an important role in phosphate regulation. Its clinical relevance in cats with CKD has not been explored…”
    Get full text
    Journal Article
  5. 5

    Fibroblast Growth Factor 23 in Feline Chronic Kidney Disease by Geddes, R.F., Finch, N.C., Elliott, J., Syme, H.M.

    Published in Journal of veterinary internal medicine (01-03-2013)
    “…Background Fibroblast growth factor 23 (FGF‐23) is a phosphaturic hormone involved in the pathogenesis of secondary renal hyperparathyroidism (SRHP) in humans…”
    Get full text
    Journal Article
  6. 6

    Association of urinary cadmium excretion with feline hypertension by Finch, N. C., Syme, H. M., Elliott, J.

    Published in Veterinary record (04-02-2012)
    “…Fifty client-owned senior cats (32 normotensive and 18 hypertensive) with renal function ranging from normal to moderately reduced were recruited into a…”
    Get full text
    Journal Article
  7. 7

    Chronic lymphocytic leukemia presenting with symptomatic central nervous system involvement by AKINTOLA-OGUNREMI, O, WHITNEY, C, MATHUR, S. C, FINCH, C. N

    Published in Annals of hematology (01-07-2002)
    “…Leukemic infiltration of the central nervous system (CNS) resulting in neurological manifestations is a rare complication of chronic lymphocytic leukemia…”
    Get full text
    Journal Article
  8. 8

    Determination of Extracellular Fluid Volume in Healthy and Azotemic Cats by Finch, N.C., Heiene, R., Elliott, J., Syme, H.M., Peters, A.M.

    Published in Journal of veterinary internal medicine (01-01-2015)
    “…Background Methods for determining extracellular fluid volume (ECFV) are important clinically for cats. Bromide dilution has been studied in cats to estimate…”
    Get full text
    Journal Article
  9. 9

    Mutation in the Gene Encoding the α Chain of Platelet Glycoprotein Ib in Platelet-Type von Willebrand Disease by Miller, Jonathan L., Cunningham, David, Lyle, Vicki A., Finch, Clara N.

    “…Platelet-type von Willebrand disease (PT-vWD) is an autosomal dominant bleeding disorder characterized by abnormally enhanced binding of von Willebrand factor…”
    Get full text
    Journal Article
  10. 10

    A Single Sample Method for Estimating Glomerular Filtration Rate in Cats by Finch, N.C., Heiene, R., Elliott, J., Syme, H.M., Peters, A.M.

    Published in Journal of veterinary internal medicine (01-07-2013)
    “…Background Validated methods of estimating glomerular filtration rate (GFR) in cats requiring only a limited number of samples are desirable…”
    Get full text
    Journal Article
  11. 11

    Primary nodal marginal zone B-cell lymphoma arising from more than one clonal neoplastic population by Finch, C N, Nichols, M, Shrimpton, A, Liu, D, Hutchison, R E

    “…Primary nodal marginal zone B-cell lymphoma is an uncommon monoclonal B-cell lymphoproliferative disorder. We report a case of a 79-year-old woman who…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Evidence that an abnormality in the glycoprotein Ib alpha gene is not the cause of abnormal platelet function in a family with classic Bernard-Soulier disease by FINCH, C. N, MILLER, J. L, LYLE, V. A, HANDIN, R. I

    Published in Blood (15-06-1990)
    “…The underlying molecular basis for Bernard-Soulier Disease (BSD) is currently unknown. Platelets from patients with this autosomal recessive bleeding disorder…”
    Get full text
    Journal Article
  14. 14

    The IgG subclasses of platelet‐associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura by Chan, Howard, Moore, Jane C., Finch, Clara N., Warkentin, Theodore E., Kelton, John G.

    Published in British journal of haematology (01-09-2003)
    “…The majority of patients with idiopathic thrombocytopenic purpura (ITP) have antiplatelet autoantibodies that are most frequently directed against platelet…”
    Get full text
    Journal Article
  15. 15

    Dissociation between the level of von Willebrand factor‐cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura by Snider, Carolyn E., Moore, Jane C., Warkentin, Theodore E., Finch, Clara N., Hayward, Catherine P.M., Kelton, John G.

    Published in American journal of hematology (01-12-2004)
    “…Decreased von Willebrand factor (VWF)‐cleaving protease activity (<5%) has been implicated in patients with congenital thrombotic thrombocytopenic…”
    Get full text
    Journal Article
  16. 16

    Evidence that an abnormality in the glycoprotein Ib alpha gene is not the cause of abnormal platelet function in a family with classic Bernard-Soulier disease by Finch, CN, Miller, JL, Lyle, VA, Handin, RI

    Published in Blood (15-06-1990)
    “…The underlying molecular basis for Bernard-Soulier Disease (BSD) is currently unknown. Platelets from patients with this autosomal recessive bleeding disorder…”
    Get full text
    Journal Article